Market Recap — July 15, 2026
Recap of insider activity, SEC filings, and market-moving news for July 15, 2026.
Last generated Sep 17, 2026, 3:35 AM ET
Top Importance Today
Filings and news with the highest AI-ranked importance score.
Inotiv's Chapter 11 Plan Confirmed — Existing Equity to Be Cancelled, No Recovery for Shareholders
GrowHub Inks Definitive Reverse Merger with EnChem America at $400M Valuation
GSK closes $10.6B Nuvalent buyout; shares head for delisting
Stripe and Advent Make Unsolicited $53B Bid for PayPal at $60.50/Share
Stripe and Advent Offer $53B+ to Acquire PayPal at $60.50/Share
General Fusion Goes Public with $170M in Cash, but a Going Concern Warning and a Heavily Dilutive Capital Structure Cloud the Debut
Wetour Robotics Seeks 200,000-Fold Share Authorization Hike and Dual-Class Voting
Banzai Registers 15M Shares for Yorkville Resale After Exhausting $100M SEPA
Viking Amends F-4 to Reflect Revised Merger Terms, Pro Forma Dilution, and a Material Weakness
International Stem Cell Corp to Sell Lifeline Cell Technology for $25M, Transforming Cash Position
Alpha Compute Corp 20-F Flags Going Concern, Control Weaknesses, and Nasdaq Delisting Threat
Chi Special Acquisition Corp. 10-K Exposes Going Concern Doubt, Material Weaknesses, and a Near-Empty Treasury
Largest Open-Market Insider Buys
Form 4 open-market purchases ranked by dollar amount.
Largest Open-Market Insider Sells
Form 4 open-market sales ranked by dollar amount.
No open-market insider sells reported on this date.
Notable 8-Ks and News
Material events and breaking news with importance score 6 or higher.
Inotiv's Chapter 11 Plan Confirmed — Existing Equity to Be Cancelled, No Recovery for Shareholders
GSK closes $10.6B Nuvalent buyout; shares head for delisting
Stripe and Advent Make Unsolicited $53B Bid for PayPal at $60.50/Share
Stripe and Advent Offer $53B+ to Acquire PayPal at $60.50/Share
International Stem Cell Corp to Sell Lifeline Cell Technology for $25M, Transforming Cash Position
NextEra, Dominion File for Regulatory Approval of $62B Merger, Pledge $2.25B in Customer Credits
Glucotrack Closes Reverse Merger with Lokahi Therapeutics, Locks in $4.45M Bridge Financing, and Opens a $50M Equity Line
Q32 Bio Prices $200M Public Offering at $18.25/Share, Riding Positive Phase 2a Data
PCSC Shareholders Clear Final Hurdle, Approving SPAC Merger with Freenome
CMCT Defaults on $97.1M Mortgage at 1 Kaiser Plaza — Lender Demands Full Payment
Form 144 Notices
Notices that restricted shares may be sold soon — often a precursor to insider selling.
Day boundary: 00:00 ET (America/New_York). Filings accepted late may appear in the next day's recap.